H.R. 5162

119 HR 5162 IH: Colorectal Cancer Early Detection Act
 U.S. House of Representatives
 2025-09-04
 text/xml
 EN
 Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.
 I  119th CONGRESS  1st Session  H. R. 5162  IN THE HOUSE OF REPRESENTATIVES   September 4, 2025   Ms. Stevens  (for herself and  Mr. Burchett ) introduced the following bill; which was referred to the  Committee on Energy and Commerce    A BILL
To authorize the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, to make grants to States to increase awareness and education for colorectal cancer and improve early detection of colorectal cancer in young individuals, and for other purposes.
1.
Short title
This Act may be cited as the   Colorectal Cancer Early Detection Act  .
2.
Findings
Congress finds the following:
(1)
In the United States, colorectal cancer is the third leading cause of cancer-related deaths in men and the fourth leading cause in women. Colorectal cancer is the second most common cause of cancer deaths when numbers for men and women are combined.
(2)
In the United States, there were over 141,000 new colorectal cancer cases and 52,000 new colorectal cancer deaths reported in 2021. It is estimated that there will be over 154,270 new cases of colorectal cancer and 52,900 cases of colorectal cancer deaths in 2025.
(3)
Colorectal cancer rates have been increasing in young patients. About 1 in 5 cases of colorectal cancer were in individuals age 54 and younger.
(4)
In early 2023, it was reported that about 20 percent of diagnoses of colorectal cancer were among patients under the age of 55. Additionally, half of all early-onset colorectal cancer cases are diagnosed in individuals under 45 years old.
(5)
Colorectal cancer cases among individuals ages 20 to 39 are expected to increase by 90 percent by 2030. Additionally, colorectal cancer is projected to be the leading cause of cancer-related deaths for individuals under 50 years of age by 2030.
3.
CDC State grants for colorectal cancer awareness, education, and early detection among young individuals
(a)
Definitions
In this section:
(1)
State
The term  State  means each of the several States, the District of Columbia, and any territory or possession of the United States.
(2)
Young individual
The term  young individual  means an individual who has not attained the age of 45.
(b)
In general
The Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention, (in this section referred to as the  Secretary ) may make grants to States, on a competitive basis, for the purpose of increasing awareness and education for colorectal cancer and early detection of colorectal cancer in young individuals.
(c)
Application
To be eligible for a grant under this section, a State shall submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require, including a detailed description of the State’s plan to implement the grant. Such description shall include how the State will use the grant to—
(1)
conduct outreach and education regarding incidence of colorectal cancer and risk factors, with an emphasis on—
(A)
young individuals with an increased risk or high risk for colorectal cancer, including—
(i)
young individuals with a family history of colorectal cancer or advanced adenomatous polyps;
(ii)
young individuals with a personal history of inflammatory bowel disease (commonly known as  IBD ), including ulcerative colitis and Crohn’s disease of the colon;
(iii)
young individuals with an inherited syndrome, including Lynch syndrome, familial adenomatous polyposis, and other inherited syndromes linked to colorectal cancer;
(iv)
young individuals with signs and symptoms of colorectal cancer, particularly rectal bleeding and iron deficiency anemia; and
(v)
other young individuals with risk factors (such as risk factors identified by nationally recognized guidelines) that put such individuals at increased risk for colorectal cancer, as determined by the Secretary; and
(B)
individuals in underserved and rural areas, individuals who identify as American Indian, Alaska Native, or African American, and individuals with type 2 diabetes, for the purposes of—
(i)
identifying individuals who are at increased risk or high risk for colorectal cancer (including young individuals described in clauses (i) through (v) of subparagraph (A)) and would benefit from early detection before age 45; and
(ii)
providing education to initiate early detection at age 45 for individuals who are not at increased risk or high risk for colorectal cancer;
(2)
partner with hospitals, clinics, Tribal organizations (as defined in section 4 of the Indian Self-Determination and Education Assistance Act), nonprofit organizations, institutions of higher education, colorectal cancer prevention and control programs, and other relevant entities and programs to enhance outreach, education, and early detection efforts with respect to colorectal cancer in young individuals; and
(3)
conduct activities to increase awareness and education for colorectal cancer and improve early detection of colorectal cancer in young individuals, including navigation and program evaluation.
(d)
Use of funds
A grant under this section may be used for any of the following:
(1)
To support early detection and diagnostic testing for colorectal cancer in young individuals deemed to be at increased risk or high risk of colorectal cancer as part of a preventive health measure strategy.
(2)
To provide appropriate referrals for medical treatment, including genetic testing and counseling of such young individuals, and to ensure, to the extent practicable, the provision of appropriate follow-up and surveillance services.
(3)
To develop and implement a public awareness and education campaign for the early detection, signs and symptoms, risk factors, and control management of colorectal cancer, specifically in young individuals.
(4)
To conduct education and outreach to health professionals (including allied health professionals) on conducting and interpreting colorectal cancer screening and diagnostic tests and the latest advancements in the early detection of colorectal cancer, with a focus on symptoms, genetic risk factors, family history, and care for young individuals.
(5)
To establish mechanisms through which the States can monitor the quality of screening and diagnostic procedures for colorectal cancer among young individuals, including the interpretation of such procedures.
(6)
To conduct surveillance to help determine other risk factors for colorectal cancer.
(7)
To develop strategies to capture and assess family history and genetic predispositions to colorectal cancer in young individuals.
(8)
To establish patient navigation support to assist individuals through the process of screening, particularly those at increased risk or high risk for colorectal cancer.
(9)
To design clinician decision support tools based on clinical practice guidelines for early detection of colorectal cancer in young individuals.
(10)
To monitor and evaluate activities conducted under paragraphs (1) through (9) to determine the effectiveness of such activities to inform continuous improvement of such activities.
(e)
Grant period
A grant under this section shall be for a period of 5 years, and may be renewed at the discretion of the Secretary.
(f)
Return of unspent grant funds
Each State that receives a grant under this section shall return, not later than 6 months after the date on which the period of such grant ends, any grant funds that were not expended by such State during the grant period.
(g)
Report
Not later than 5 years after receiving a grant under this section (including a renewal of a grant), a State shall submit to the Secretary a report describing how the State used such grant.